Loading clinical trials...
Loading clinical trials...
The purpose of this study is to make a standardized and scalable Rasch-built clinical severity scale to help in finding genetic and environmental modifiers of disease in Facioscapulohumeral muscular d...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Kansas Medical Center
Collaborators
NCT06907875 · Facioscapulohumeral Muscular Dystrophy
NCT00082108 · Myotonic Dystrophy, Facioscapulohumeral Muscular Dystrophy, and more
NCT06708468 · Neuromuscular Diseases (NMD), Charcot Marie Tooth Disease (CMT), and more
NCT03458832 · Facioscapulohumeral Muscular Dystrophy
NCT06911190 · FSHD - Facioscapulohumeral Muscular Dystrophy
University of Kansas Medical Center
Kansas City, Kansas
University of Utah
Salt Lake City, Utah
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions